English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 111 | Tables: 113 | Medical Devices & Consumables
The global Autism Diagnostic market was valued at US$ 12045 million in 2025 and is anticipated to reach US$ 16303 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Autism Diagnostic refers to a healthcare and medical evaluation system used to identify and assess whether an individual has Autism Spectrum Disorder (ASD) and to determine the severity and developmental characteristics of the condition. In clinical practice, autism diagnosis is typically conducted by multidisciplinary teams including pediatricians, psychiatrists, psychologists, and speech or behavioral therapists. The process involves standardized assessment tools, behavioral observation scales, neurodevelopmental evaluations, and in some cases biological testing. With the advancement of medical technologies, autism diagnostics increasingly incorporate digital assessment tools, artificial intelligence–based analysis, and genetic testing to improve diagnostic accuracy and efficiency. In addition, autism diagnosis is closely connected with subsequent therapeutic interventions, including behavioral therapy, rehabilitation training, pharmacological treatment, and family support programs. As public awareness of neurodevelopmental disorders increases and early screening systems continue to improve, autism diagnostic and treatment services are becoming an increasingly important component of pediatric healthcare and mental health management worldwide.The average gross profit margin of this product is 29%.
As global awareness of neurodevelopmental disorders continues to increase, early screening and diagnosis of autism are receiving growing attention from healthcare institutions, educational organizations, and families. Many countries are strengthening child developmental screening programs and mental health evaluation systems, which is driving demand for autism diagnostic and treatment services. Meanwhile, the development of digital healthcare technologies, artificial intelligence–based assessment tools, and telemedicine platforms has made autism screening and diagnosis more efficient and accessible, especially in regions with limited medical resources. In addition, increasing government and social investment in child mental health and special education programs is providing strong support for the growth of the autism diagnostic and treatment market.
Despite increasing demand, the autism diagnostic and treatment industry faces several challenges. Autism is a complex neurodevelopmental condition with highly variable symptoms among individuals, making diagnosis dependent on long-term observation and multidimensional evaluation. This requires highly trained professionals and reliable assessment tools. In addition, disparities in healthcare infrastructure, the availability of trained specialists, and public awareness across regions may limit the accessibility of diagnostic services. Furthermore, autism treatment often involves long-term intervention and multidisciplinary collaboration, requiring significant financial and professional resources, which may constrain market expansion.
Downstream demand for autism diagnostic and treatment services mainly comes from pediatric hospitals, mental health institutions, rehabilitation centers, and special education organizations. As early intervention becomes more widely recognized, an increasing number of families seek professional developmental assessments at an early stage to initiate timely rehabilitation and behavioral therapy. Educational institutions and social service organizations are also strengthening support systems for individuals with autism, including special education programs, rehabilitation training services, and family support initiatives. In addition, the adoption of telehealth platforms and digital diagnostic tools is expanding service accessibility, allowing more families to access professional diagnostic and treatment resources.
The upstream ecosystem of the autism diagnostic and treatment industry mainly includes diagnostic assessment tools, medical testing technologies, digital software platforms, and related therapeutic equipment and medications. Standardized behavioral assessment scales and psychological evaluation tools form the foundation of diagnostic procedures, while neuroimaging technologies, genetic testing methods, and data analytics platforms provide supportive diagnostic insights. In the treatment phase, rehabilitation training equipment, educational software, and behavioral intervention tools play important roles. With the advancement of artificial intelligence and digital healthcare technologies, upstream technical platforms are continuously evolving, providing more accurate and efficient support for autism diagnosis and treatment services.
This report delivers a comprehensive overview of the global Autism Diagnostic market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Autism Diagnostic. The Autism Diagnostic market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Autism Diagnostic market comprehensively. Regional market sizes by Type, by Application, by Diagnostic Method, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Autism Diagnostic manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Novartis
Teva
Johnson & Johnson
Otsuka
Indivior
Viatris
Aurobindo
Lundbeck
Qilu Pharma
Bio-Techne
Bluesprig
Action Behavior Centers (ABA)
Cognoa
Hopebridge
Segment by Type
Behavioral Approaches
Early Intervention
Drug Therapies
Others
Segment by Diagnostic Method
Hospitals
Autism Centers
Rehab Clinics
Segment by Application
Children
Teenager
Adults
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Diagnostic Method, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Autism Diagnostic companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autism Diagnostic Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Behavioral Approaches
1.2.3 Early Intervention
1.2.4 Drug Therapies
1.2.5 Others
1.3 Market by Diagnostic Method
1.3.1 Global Autism Diagnostic Market Size Growth Rate by Diagnostic Method: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Autism Centers
1.3.4 Rehab Clinics
1.4 Market by Application
1.4.1 Global Autism Diagnostic Market Growth by Application: 2021 vs 2025 vs 2032
1.4.2 Children
1.4.3 Teenager
1.4.4 Adults
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Autism Diagnostic Market Perspective (2021–2032)
2.2 Global Autism Diagnostic Growth Trends by Region
2.2.1 Global Autism Diagnostic Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Autism Diagnostic Historic Market Size by Region (2021–2026)
2.2.3 Autism Diagnostic Forecasted Market Size by Region (2027–2032)
2.3 Autism Diagnostic Market Dynamics
2.3.1 Autism Diagnostic Industry Trends
2.3.2 Autism Diagnostic Market Drivers
2.3.3 Autism Diagnostic Market Challenges
2.3.4 Autism Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autism Diagnostic Players by Revenue
3.1.1 Global Top Autism Diagnostic Players by Revenue (2021–2026)
3.1.2 Global Autism Diagnostic Revenue Market Share by Players (2021–2026)
3.2 Global Top Autism Diagnostic Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Autism Diagnostic Revenue
3.4 Global Autism Diagnostic Market Concentration Ratio
3.4.1 Global Autism Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autism Diagnostic Revenue in 2025
3.5 Global Key Players of Autism Diagnostic Head Offices and Areas Served
3.6 Global Key Players of Autism Diagnostic, Products and Applications
3.7 Global Key Players of Autism Diagnostic, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Autism Diagnostic Breakdown Data by Type
4.1 Global Autism Diagnostic Historic Market Size by Type (2021–2026)
4.2 Global Autism Diagnostic Forecasted Market Size by Type (2027–2032)
5 Autism Diagnostic Breakdown Data by Application
5.1 Global Autism Diagnostic Historic Market Size by Application (2021–2026)
5.2 Global Autism Diagnostic Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Autism Diagnostic Market Size (2021–2032)
6.2 North America Autism Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Autism Diagnostic Market Size by Country (2021–2026)
6.4 North America Autism Diagnostic Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autism Diagnostic Market Size (2021–2032)
7.2 Europe Autism Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Autism Diagnostic Market Size by Country (2021–2026)
7.4 Europe Autism Diagnostic Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Autism Diagnostic Market Size (2021–2032)
8.2 Asia-Pacific Autism Diagnostic Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Autism Diagnostic Market Size by Region (2021–2026)
8.4 Asia-Pacific Autism Diagnostic Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Autism Diagnostic Market Size (2021–2032)
9.2 Latin America Autism Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Autism Diagnostic Market Size by Country (2021–2026)
9.4 Latin America Autism Diagnostic Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autism Diagnostic Market Size (2021–2032)
10.2 Middle East & Africa Autism Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Autism Diagnostic Market Size by Country (2021–2026)
10.4 Middle East & Africa Autism Diagnostic Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Autism Diagnostic Introduction
11.1.4 Pfizer Revenue in Autism Diagnostic Business (2021–2026)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Autism Diagnostic Introduction
11.2.4 Novartis Revenue in Autism Diagnostic Business (2021–2026)
11.2.5 Novartis Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Autism Diagnostic Introduction
11.3.4 Teva Revenue in Autism Diagnostic Business (2021–2026)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Autism Diagnostic Introduction
11.4.4 Johnson & Johnson Revenue in Autism Diagnostic Business (2021–2026)
11.4.5 Johnson & Johnson Recent Development
11.5 Otsuka
11.5.1 Otsuka Company Details
11.5.2 Otsuka Business Overview
11.5.3 Otsuka Autism Diagnostic Introduction
11.5.4 Otsuka Revenue in Autism Diagnostic Business (2021–2026)
11.5.5 Otsuka Recent Development
11.6 Indivior
11.6.1 Indivior Company Details
11.6.2 Indivior Business Overview
11.6.3 Indivior Autism Diagnostic Introduction
11.6.4 Indivior Revenue in Autism Diagnostic Business (2021–2026)
11.6.5 Indivior Recent Development
11.7 Viatris
11.7.1 Viatris Company Details
11.7.2 Viatris Business Overview
11.7.3 Viatris Autism Diagnostic Introduction
11.7.4 Viatris Revenue in Autism Diagnostic Business (2021–2026)
11.7.5 Viatris Recent Development
11.8 Aurobindo
11.8.1 Aurobindo Company Details
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Autism Diagnostic Introduction
11.8.4 Aurobindo Revenue in Autism Diagnostic Business (2021–2026)
11.8.5 Aurobindo Recent Development
11.9 Lundbeck
11.9.1 Lundbeck Company Details
11.9.2 Lundbeck Business Overview
11.9.3 Lundbeck Autism Diagnostic Introduction
11.9.4 Lundbeck Revenue in Autism Diagnostic Business (2021–2026)
11.9.5 Lundbeck Recent Development
11.10 Qilu Pharma
11.10.1 Qilu Pharma Company Details
11.10.2 Qilu Pharma Business Overview
11.10.3 Qilu Pharma Autism Diagnostic Introduction
11.10.4 Qilu Pharma Revenue in Autism Diagnostic Business (2021–2026)
11.10.5 Qilu Pharma Recent Development
11.11 Bio-Techne
11.11.1 Bio-Techne Company Details
11.11.2 Bio-Techne Business Overview
11.11.3 Bio-Techne Autism Diagnostic Introduction
11.11.4 Bio-Techne Revenue in Autism Diagnostic Business (2021–2026)
11.11.5 Bio-Techne Recent Development
11.12 Bluesprig
11.12.1 Bluesprig Company Details
11.12.2 Bluesprig Business Overview
11.12.3 Bluesprig Autism Diagnostic Introduction
11.12.4 Bluesprig Revenue in Autism Diagnostic Business (2021–2026)
11.12.5 Bluesprig Recent Development
11.13 Action Behavior Centers (ABA)
11.13.1 Action Behavior Centers (ABA) Company Details
11.13.2 Action Behavior Centers (ABA) Business Overview
11.13.3 Action Behavior Centers (ABA) Autism Diagnostic Introduction
11.13.4 Action Behavior Centers (ABA) Revenue in Autism Diagnostic Business (2021–2026)
11.13.5 Action Behavior Centers (ABA) Recent Development
11.14 Cognoa
11.14.1 Cognoa Company Details
11.14.2 Cognoa Business Overview
11.14.3 Cognoa Autism Diagnostic Introduction
11.14.4 Cognoa Revenue in Autism Diagnostic Business (2021–2026)
11.14.5 Cognoa Recent Development
11.15 Hopebridge
11.15.1 Hopebridge Company Details
11.15.2 Hopebridge Business Overview
11.15.3 Hopebridge Autism Diagnostic Introduction
11.15.4 Hopebridge Revenue in Autism Diagnostic Business (2021–2026)
11.15.5 Hopebridge Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Autism Diagnostic Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Behavioral Approaches
Table 3. Key Players of Early Intervention
Table 4. Key Players of Drug Therapies
Table 5. Key Players of Others
Table 6. Global Autism Diagnostic Market Size Growth Rate by Diagnostic Method (US$ Million): 2021 vs 2025 vs 2032
Table 7. Key Players of Hospitals
Table 8. Key Players of Autism Centers
Table 9. Key Players of Rehab Clinics
Table 10. Key Players of Behavioral Assessment
Table 11. Key Players of Developmental Screening
Table 12. Key Players of Genetic Testing
Table 13. Key Players of Neuroimaging Analysis
Table 14. Key Players of Others
Table 15. Global Autism Diagnostic Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global Autism Diagnostic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Autism Diagnostic Market Size by Region (US$ Million), 2021–2026
Table 18. Global Autism Diagnostic Market Share by Region (2021–2026)
Table 19. Global Autism Diagnostic Forecasted Market Size by Region (US$ Million), 2027–2032
Table 20. Global Autism Diagnostic Market Share by Region (2027–2032)
Table 21. Autism Diagnostic Market Trends
Table 22. Autism Diagnostic Market Drivers
Table 23. Autism Diagnostic Market Challenges
Table 24. Autism Diagnostic Market Restraints
Table 25. Global Autism Diagnostic Revenue by Players (US$ Million), 2021–2026
Table 26. Global Autism Diagnostic Market Share by Players (2021–2026)
Table 27. Global Top Autism Diagnostic Players by Tier (Tier 1, Tier 2, and Tier 3), based on Autism Diagnostic Revenue, 2025
Table 28. Ranking of Global Top Autism Diagnostic Companies by Revenue (US$ Million) in 2025
Table 29. Global 5 Largest Players Market Share by Autism Diagnostic Revenue (CR5 and HHI), 2021–2026
Table 30. Global Key Players of Autism Diagnostic, Headquarters and Area Served
Table 31. Global Key Players of Autism Diagnostic, Products and Applications
Table 32. Global Key Players of Autism Diagnostic, Date of General Availability (GA)
Table 33. Mergers and Acquisitions, Expansion Plans
Table 34. Global Autism Diagnostic Market Size by Type (US$ Million), 2021–2026
Table 35. Global Autism Diagnostic Revenue Market Share by Type (2021–2026)
Table 36. Global Autism Diagnostic Forecasted Market Size by Type (US$ Million), 2027–2032
Table 37. Global Autism Diagnostic Revenue Market Share by Type (2027–2032)
Table 38. Global Autism Diagnostic Market Size by Application (US$ Million), 2021–2026
Table 39. Global Autism Diagnostic Revenue Market Share by Application (2021–2026)
Table 40. Global Autism Diagnostic Forecasted Market Size by Application (US$ Million), 2027–2032
Table 41. Global Autism Diagnostic Revenue Market Share by Application (2027–2032)
Table 42. North America Autism Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. North America Autism Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 44. North America Autism Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 45. Europe Autism Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Europe Autism Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 47. Europe Autism Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 48. Asia-Pacific Autism Diagnostic Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 49. Asia-Pacific Autism Diagnostic Market Size by Region (US$ Million), 2021–2026
Table 50. Asia-Pacific Autism Diagnostic Market Size by Region (US$ Million), 2027–2032
Table 51. Latin America Autism Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Latin America Autism Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 53. Latin America Autism Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 54. Middle East & Africa Autism Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 55. Middle East & Africa Autism Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 56. Middle East & Africa Autism Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 57. Pfizer Company Details
Table 58. Pfizer Business Overview
Table 59. Pfizer Autism Diagnostic Product
Table 60. Pfizer Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 61. Pfizer Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Autism Diagnostic Product
Table 65. Novartis Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 66. Novartis Recent Development
Table 67. Teva Company Details
Table 68. Teva Business Overview
Table 69. Teva Autism Diagnostic Product
Table 70. Teva Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 71. Teva Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Autism Diagnostic Product
Table 75. Johnson & Johnson Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 76. Johnson & Johnson Recent Development
Table 77. Otsuka Company Details
Table 78. Otsuka Business Overview
Table 79. Otsuka Autism Diagnostic Product
Table 80. Otsuka Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 81. Otsuka Recent Development
Table 82. Indivior Company Details
Table 83. Indivior Business Overview
Table 84. Indivior Autism Diagnostic Product
Table 85. Indivior Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 86. Indivior Recent Development
Table 87. Viatris Company Details
Table 88. Viatris Business Overview
Table 89. Viatris Autism Diagnostic Product
Table 90. Viatris Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 91. Viatris Recent Development
Table 92. Aurobindo Company Details
Table 93. Aurobindo Business Overview
Table 94. Aurobindo Autism Diagnostic Product
Table 95. Aurobindo Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 96. Aurobindo Recent Development
Table 97. Lundbeck Company Details
Table 98. Lundbeck Business Overview
Table 99. Lundbeck Autism Diagnostic Product
Table 100. Lundbeck Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 101. Lundbeck Recent Development
Table 102. Qilu Pharma Company Details
Table 103. Qilu Pharma Business Overview
Table 104. Qilu Pharma Autism Diagnostic Product
Table 105. Qilu Pharma Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 106. Qilu Pharma Recent Development
Table 107. Bio-Techne Company Details
Table 108. Bio-Techne Business Overview
Table 109. Bio-Techne Autism Diagnostic Product
Table 110. Bio-Techne Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 111. Bio-Techne Recent Development
Table 112. Bluesprig Company Details
Table 113. Bluesprig Business Overview
Table 114. Bluesprig Autism Diagnostic Product
Table 115. Bluesprig Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 116. Bluesprig Recent Development
Table 117. Action Behavior Centers (ABA) Company Details
Table 118. Action Behavior Centers (ABA) Business Overview
Table 119. Action Behavior Centers (ABA) Autism Diagnostic Product
Table 120. Action Behavior Centers (ABA) Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 121. Action Behavior Centers (ABA) Recent Development
Table 122. Cognoa Company Details
Table 123. Cognoa Business Overview
Table 124. Cognoa Autism Diagnostic Product
Table 125. Cognoa Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 126. Cognoa Recent Development
Table 127. Hopebridge Company Details
Table 128. Hopebridge Business Overview
Table 129. Hopebridge Autism Diagnostic Product
Table 130. Hopebridge Revenue in Autism Diagnostic Business (US$ Million), 2021–2026
Table 131. Hopebridge Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
Table 135. Authors List of This Report
List of Figures
Figure 1. Autism Diagnostic Picture
Figure 2. Global Autism Diagnostic Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Autism Diagnostic Market Share by Type: 2025 vs 2032
Figure 4. Behavioral Approaches Features
Figure 5. Early Intervention Features
Figure 6. Drug Therapies Features
Figure 7. Others Features
Figure 8. Global Autism Diagnostic Market Size Comparison by Diagnostic Method (US$ Million), 2021–2032
Figure 9. Hospitals Features
Figure 10. Autism Centers Features
Figure 11. Rehab Clinics Features
Figure 12. Behavioral Assessment Features
Figure 13. Developmental Screening Features
Figure 14. Genetic Testing Features
Figure 15. Neuroimaging Analysis Features
Figure 16. Others Features
Figure 17. Global Autism Diagnostic Market Size by Application (US$ Million), 2021–2032
Figure 18. Global Autism Diagnostic Market Share by Application: 2025 vs 2032
Figure 19. Children Case Studies
Figure 20. Teenager Case Studies
Figure 21. Adults Case Studies
Figure 22. Autism Diagnostic Report Years Considered
Figure 23. Global Autism Diagnostic Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 24. Global Autism Diagnostic Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Autism Diagnostic Market Share by Region: 2025 vs 2032
Figure 26. Global Autism Diagnostic Market Share by Players in 2025
Figure 27. Global Autism Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Autism Diagnostic Revenue in 2025
Figure 29. North America Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. North America Autism Diagnostic Market Share by Country (2021–2032)
Figure 31. United States Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Canada Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Europe Autism Diagnostic Market Share by Country (2021–2032)
Figure 35. Germany Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. France Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. U.K. Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Italy Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Russia Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Ireland Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Asia-Pacific Autism Diagnostic Market Share by Region (2021–2032)
Figure 43. China Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Japan Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. South Korea Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Southeast Asia Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. India Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Australia & New Zealand Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Latin America Autism Diagnostic Market Share by Country (2021–2032)
Figure 51. Mexico Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Brazil Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Middle East & Africa Autism Diagnostic Market Share by Country (2021–2032)
Figure 55. Israel Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Saudi Arabia Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. UAE Autism Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Pfizer Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 59. Novartis Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 60. Teva Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 61. Johnson & Johnson Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 62. Otsuka Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 63. Indivior Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 64. Viatris Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 65. Aurobindo Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 66. Lundbeck Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 67. Qilu Pharma Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 68. Bio-Techne Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 69. Bluesprig Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 70. Action Behavior Centers (ABA) Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 71. Cognoa Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 72. Hopebridge Revenue Growth Rate in Autism Diagnostic Business (2021–2026)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
